| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.602 | 0.003 | 0.602 | Insulin sensitizer | 0.489 0.004 DBMET01401 | ||
| 0.601 | 0.018 | 0.601 | Cholesterol antagonist | 0.478 0.036 DBMET01401 | ||
| 0.565 | 0.009 | 0.57 | Platelet antagonist | 0.57 0.008 DBMET01401 | DBMET01401 | |
| 0.567 | 0.02 | 0.567 | Antithrombotic | 0.498 0.029 DBMET01401 | ||
| 0.548 | 0.021 | 0.548 | Vasodilator, peripheral | 0.436 0.045 DBMET01401 | ||
| 0.508 | 0.004 | 0.508 | Tyrosine 3 hydroxylase inhibitor | 0.459 0.005 DBMET01401 | ||
| 0.505 | 0.023 | 0.505 | Calpain 2 inhibitor | 0.444 0.041 DBMET01401 | ||
| 0.483 | 0.012 | 0.483 | Psychostimulant | 0.462 0.015 DBMET01401 | ||
| 0.484 | 0.031 | 0.484 | Immunostimulant | 0.445 0.038 DBMET01401 | ||
| 0.479 | 0.031 | 0.479 | 5 Hydroxytryptamine release stimulant | 0.417 0.042 DBMET01401 | ||
| 0.479 | 0.037 | 0.479 | Histamine release inhibitor | 0.409 0.071 DBMET01401 | ||
| 0.446 | 0.028 | 0.457 | Apoptosis antagonist | 0.457 0.026 DBMET01401 | DBMET01401 | |
| 0.416 | 0.012 | 0.422 | Diuretic | 0.422 0.012 DBMET01401 | DBMET01401 | |
| 0.42 | 0.019 | 0.432 | Insulysin inhibitor | 0.432 0.017 DBMET01401 | DBMET01401 | |
| 0.402 | 0.005 | 0.402 | Phospholipase A2 inhibitor | 0.358 0.007 DBMET01401 | ||
| 0.414 | 0.017 | 0.429 | Interleukin agonist | 0.429 0.015 DBMET01401 | DBMET01401 | |
| 0.4 | 0.016 | 0.448 | Growth hormone agonist | 0.448 0.01 DBMET01401 | DBMET01401 | |
| 0.394 | 0.01 | 0.394 | Calpain inhibitor | 0.355 0.016 DBMET01401 | ||
| 0.428 | 0.062 | 0.428 | 5 Hydroxytryptamine release inhibitor | 0.358 0.109 DBMET01401 | ||
| 0.371 | 0.005 | 0.43 | Aminopeptidase B inhibitor | 0.43 0.004 DBMET01401 | DBMET01401 | |
| 0.383 | 0.023 | 0.404 | Sodium/bile acid cotransporter inhibitor | 0.404 0.016 DBMET01401 | DBMET01401 | |
| 0.363 | 0.004 | 0.363 | Catalase inhibitor | 0.343 0.005 DBMET01401 | ||
| 0.388 | 0.03 | 0.388 | Hypoglycemic | 0.308 0.05 DBMET01401 | ||
| 0.352 | 0.01 | 0.366 | Gastrin inhibitor | 0.366 0.008 DBMET01401 | DBMET01401 | |
| 0.349 | 0.015 | 0.349 | Thiol protease inhibitor | 0.315 0.018 DBMET01401 | ||
| 0.397 | 0.064 | 0.397 | Immunosuppressant | 0.396 0.065 DBMET01401 | ||
| 0.339 | 0.008 | 0.422 | Cell adhesion inhibitor | 0.422 0.005 DBMET01401 | DBMET01401 | |
| 0.375 | 0.044 | 0.375 | Vasodilator, coronary | 0.301 0.086 DBMET01401 | ||
| 0.361 | 0.037 | 0.42 | Interleukin antagonist | 0.42 0.028 DBMET01401 | DBMET01401 | |
| 0.354 | 0.031 | 0.375 | Angiogenesis stimulant | 0.375 0.026 DBMET01401 | DBMET01401 | |
| 0.348 | 0.036 | 0.348 | Hypolipemic | 0.332 0.04 DBMET01401 | ||
| 0.355 | 0.043 | 0.391 | Interleukin 2 agonist | 0.391 0.03 DBMET01401 | DBMET01401 | |
| 0.377 | 0.069 | 0.377 | Transcription factor NF kappa B inhibitor | 0.329 0.083 DBMET01401 | ||
| 0.395 | 0.094 | 0.395 | Cyclophilin D inhibitor | 0.392 0.096 DBMET01401 | ||
| 0.314 | 0.013 | 0.323 | Neurotensin receptor agonist | 0.323 0.012 DBMET01401 | DBMET01401 | |
| 0.288 | 0.005 | 0.298 | Toll-Like receptor 2 antagonist | 0.298 0.005 DBMET01401 | DBMET01401 | |
| 0.336 | 0.057 | 0.336 | Spasmolytic | 0.173 0.143 DBMET01401 | ||
| 0.304 | 0.052 | 0.342 | Transcription factor STAT3 inhibitor | 0.342 0.036 DBMET01401 | DBMET01401 | |
| 0.279 | 0.028 | 0.372 | Thrombolytic | 0.372 0.014 DBMET01401 | DBMET01401 | |
| 0.265 | 0.014 | 0.267 | Proteasome inhibitor | 0.267 0.013 DBMET01401 | DBMET01401 | |
| 0.27 | 0.021 | 0.27 | Bone formation stimulant | 0.222 0.03 DBMET01401 | ||
| 0.263 | 0.018 | 0.288 | Succinate dehydrogenase inhibitor | 0.288 0.013 DBMET01401 | DBMET01401 | |
| 0.282 | 0.038 | 0.282 | Anesthetic general | 0.263 0.045 DBMET01401 | ||
| 0.244 | 0.005 | 0.244 | Caspase 3 inhibitor | 0.239 0.005 DBMET01401 | ||
| 0.238 | 0.007 | 0.33 | Cell adhesion molecule inhibitor | 0.33 0.005 DBMET01401 | DBMET01401 | |
| 0.235 | 0.004 | 0.235 | Interleukin 1 beta converting enzyme inhibitor | 0.219 0.004 DBMET01401 | ||
| 0.23 | 0.003 | 0.23 | Protease 3C (Human rhinovirus) inhibitor | 0.188 0.005 DBMET01401 | ||
| 0.267 | 0.041 | 0.281 | Neuropeptide Y2 antagonist | 0.281 0.03 DBMET01401 | DBMET01401 | |
| 0.345 | 0.121 | 0.345 | Calcium channel L-type activator | 0.279 0.175 DBMET01401 | ||
| 0.23 | 0.008 | 0.23 | Photosensitizer | 0.198 0.013 DBMET01401 | ||
| 0.227 | 0.014 | 0.267 | Cathepsin G inhibitor | 0.267 0.011 DBMET01401 | DBMET01401 | |
| 0.216 | 0.006 | 0.328 | Aminopeptidase I inhibitor | 0.328 0.003 DBMET01401 | DBMET01401 | |
| 0.217 | 0.009 | 0.217 | Vanilloid 1 agonist | 0.198 0.012 DBMET01401 | ||
| 0.238 | 0.03 | 0.238 | Protein kinase stimulant | 0.231 0.032 DBMET01401 | ||
| 0.216 | 0.011 | 0.235 | Protease inhibitor | 0.235 0.009 DBMET01401 | DBMET01401 | |
| 0.244 | 0.04 | 0.269 | Anticoagulant | 0.269 0.034 DBMET01401 | DBMET01401 | |
| 0.272 | 0.072 | 0.321 | Transcription factor STAT inhibitor | 0.321 0.045 DBMET01401 | DBMET01401 | |
| 0.225 | 0.025 | 0.256 | Insulin secretagoues | 0.256 0.018 DBMET01401 | DBMET01401 | |
| 0.219 | 0.02 | 0.225 | Catenin beta inhibitor | 0.225 0.018 DBMET01401 | DBMET01401 | |
| 0.253 | 0.067 | 0.253 | Vasodilator | 0.188 0.114 DBMET01401 | ||
| 0.215 | 0.03 | 0.301 | Alpha-N-acetylglucosaminidase inhibitor | 0.301 0.016 DBMET01401 | DBMET01401 | |
| 0.277 | 0.096 | 0.277 | Immunomodulator | 0.275 0.096 DBMET01401 | ||
| 0.23 | 0.05 | 0.23 | Hepatoprotectant | 0.21 0.059 DBMET01401 | ||
| 0.189 | 0.008 | 0.189 | Toll-Like receptor 2 agonist | 0.151 0.011 DBMET01401 | ||
| 0.19 | 0.011 | 0.248 | Glutamate dehydrogenase inhibitor | 0.248 0.007 DBMET01401 | DBMET01401 | |
| 0.186 | 0.021 | 0.186 | Adenylate cyclase stimulant | 0.186 0.021 DBMET01401 | ||
| 0.174 | 0.011 | 0.224 | Matrix metalloproteinase inhibitor | 0.224 0.007 DBMET01401 | DBMET01401 | |
| 0.179 | 0.019 | 0.179 | Mucolytic | 0.155 0.029 DBMET01401 | ||
| 0.163 | 0.004 | 0.241 | Neutral endopeptidase inhibitor | 0.241 0.003 DBMET01401 | DBMET01401 | |
| 0.223 | 0.065 | 0.223 | Platelet aggregation inhibitor | 0.192 0.087 DBMET01401 | ||
| 0.16 | 0.002 | 0.16 | Lysophosphatidic acid 3 receptor antagonist | 0.151 0.003 DBMET01401 | ||
| 0.182 | 0.027 | 0.187 | Cyclooxygenase 3 inhibitor | 0.187 0.024 DBMET01401 | DBMET01401 | |
| 0.188 | 0.035 | 0.188 | Histone deacetylase SIRT1 inhibitor | 0.18 0.04 DBMET01401 | ||
| 0.241 | 0.09 | 0.364 | 5 Hydroxytryptamine uptake stimulant | 0.364 0.022 DBMET01401 | DBMET01401 | |
| 0.192 | 0.041 | 0.192 | Arachidonic acid antagonist | 0.162 0.074 DBMET01401 | ||
| 0.159 | 0.01 | 0.159 | Glutathione S-transferase inhibitor | 0.134 0.016 DBMET01401 | ||
| 0.195 | 0.047 | 0.201 | Phospholipase C inhibitor | 0.201 0.043 DBMET01401 | DBMET01401 | |
| 0.177 | 0.03 | 0.237 | Cathepsin H inhibitor | 0.237 0.015 DBMET01401 | DBMET01401 | |
| 0.158 | 0.017 | 0.261 | Metalloproteinase-2 inhibitor | 0.261 0.006 DBMET01401 | DBMET01401 | |
| 0.147 | 0.009 | 0.221 | Matrix metalloproteinase (membrane-type) inhibitor | 0.221 0.005 DBMET01401 | DBMET01401 | |
| 0.231 | 0.095 | 0.241 | Cardiotonic | 0.241 0.089 DBMET01401 | DBMET01401 | |
| 0.177 | 0.042 | 0.208 | Cell wall synthesis inhibitor | 0.208 0.027 DBMET01401 | DBMET01401 | |
| 0.203 | 0.069 | 0.203 | Platelet adhesion inhibitor | 0.179 0.083 DBMET01401 | ||
| 0.144 | 0.012 | 0.155 | Ribonucleoside-diphosphate reductase inhibitor | 0.155 0.011 DBMET01401 | DBMET01401 | |
| 0.143 | 0.012 | 0.181 | Carbonic anhydrase stimulant | 0.181 0.009 DBMET01401 | DBMET01401 | |
| 0.162 | 0.031 | 0.162 | Expectorant | 0.132 0.043 DBMET01401 | ||
| 0.135 | 0.004 | 0.149 | Glutamate (mGluR6) antagonist | 0.149 0.004 DBMET01401 | DBMET01401 | |
| 0.175 | 0.045 | 0.175 | Hemostatic | 0.137 0.086 DBMET01401 | ||
| 0.14 | 0.014 | 0.151 | Ribonucleotide reductase inhibitor | 0.151 0.012 DBMET01401 | DBMET01401 | |
| 0.135 | 0.01 | 0.168 | Aminopeptidase microsomal inhibitor | 0.168 0.005 DBMET01401 | DBMET01401 | |
| 0.224 | 0.099 | 0.224 | Antioxidant | 0.191 0.121 DBMET01401 | ||
| 0.133 | 0.012 | 0.245 | Integrin antagonist | 0.245 0.005 DBMET01401 | DBMET01401 | |
| 0.156 | 0.039 | 0.165 | Histone deacetylase class III inhibitor | 0.165 0.034 DBMET01401 | DBMET01401 | |
| 0.137 | 0.02 | 0.149 | Chymotrypsin inhibitor | 0.149 0.017 DBMET01401 | DBMET01401 | |
| 0.141 | 0.026 | 0.165 | Folate antagonist | 0.165 0.018 DBMET01401 | DBMET01401 | |
| 0.151 | 0.037 | 0.166 | Microtubule formation inhibitor | 0.166 0.03 DBMET01401 | DBMET01401 | |
| 0.142 | 0.029 | 0.249 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.249 0.01 DBMET01401 | DBMET01401 | |
| 0.118 | 0.009 | 0.132 | Caspase 9 inhibitor | 0.132 0.008 DBMET01401 | DBMET01401 | |
| 0.313 | 0.204 | 0.313 | Antiinflammatory | |||
| 0.128 | 0.02 | 0.128 | Ornithine decarboxylase inhibitor | 0.081 0.067 DBMET01401 | ||
| 0.123 | 0.016 | 0.224 | Neutrophil collagenase inhibitor | 0.224 0.006 DBMET01401 | DBMET01401 | |
| 0.116 | 0.01 | 0.149 | Aminopeptidase N inhibitor | 0.149 0.005 DBMET01401 | DBMET01401 | |
| 0.123 | 0.018 | 0.125 | 3C-Like protease (SARS coronavirus) inhibitor | 0.125 0.017 DBMET01401 | DBMET01401 | |
| 0.135 | 0.032 | 0.135 | Sphingomyelinase inhibitor | 0.126 0.037 DBMET01401 | ||
| 0.119 | 0.017 | 0.119 | Interferon agonist | 0.091 0.037 DBMET01401 | ||
| 0.185 | 0.083 | 0.194 | Non-steroidal antiinflammatory agent | 0.194 0.076 DBMET01401 | DBMET01401 | |
| 0.166 | 0.065 | 0.176 | Protein-tyrosine phosphatase inhibitor | 0.176 0.058 DBMET01401 | DBMET01401 | |
| 0.128 | 0.032 | 0.133 | Factor V inhibitor | 0.133 0.028 DBMET01401 | DBMET01401 | |
| 0.154 | 0.059 | 0.154 | Neuropeptide Y1 antagonist | 0.128 0.104 DBMET01401 | ||
| 0.145 | 0.05 | 0.145 | Antibacterial (Helicobacter pylori) | |||
| 0.113 | 0.019 | 0.16 | GABA aminotransferase inhibitor | 0.16 0.006 DBMET01401 | DBMET01401 | |
| 0.197 | 0.103 | 0.213 | Peptidyltransferase inhibitor | 0.213 0.084 DBMET01401 | DBMET01401 | |
| 0.114 | 0.021 | 0.117 | Vanilloid agonist | 0.117 0.02 DBMET01401 | DBMET01401 | |
| 0.146 | 0.055 | 0.151 | Heat shock protein 70 antagonist | 0.151 0.044 DBMET01401 | DBMET01401 | |
| 0.104 | 0.014 | 0.128 | Bombesin 2 receptor antagonist | 0.128 0.011 DBMET01401 | DBMET01401 | |
| 0.108 | 0.017 | 0.109 | Estrogen-related receptor beta agonist | 0.109 0.016 DBMET01401 | DBMET01401 | |
| 0.097 | 0.008 | 0.218 | Kainate receptor antagonist | 0.218 0.004 DBMET01401 | DBMET01401 | |
| 0.104 | 0.016 | 0.105 | Antimetabolite | 0.105 0.015 DBMET01401 | DBMET01401 | |
| 0.097 | 0.011 | 0.137 | Metalloproteinase-3 inhibitor | 0.137 0.006 DBMET01401 | DBMET01401 | |
| 0.102 | 0.017 | 0.12 | GP IIb/IIIa receptor antagonist | 0.12 0.014 DBMET01401 | DBMET01401 | |
| 0.101 | 0.019 | 0.177 | NMDA receptor agonist | 0.177 0.005 DBMET01401 | DBMET01401 | |
| 0.274 | 0.192 | 0.274 | Apoptosis agonist | 0.268 0.197 DBMET01401 | ||
| 0.093 | 0.012 | 0.093 | Nitric oxide donor | 0.077 0.025 DBMET01401 | ||
| 0.096 | 0.015 | 0.145 | Endothelin-converting enzyme inhibitor | 0.145 0.009 DBMET01401 | DBMET01401 | |
| 0.097 | 0.017 | 0.097 | Human rhinovirus A protease inhibitor | 0.09 0.019 DBMET01401 | ||
| 0.198 | 0.119 | 0.236 | Superoxide dismutase inhibitor | 0.236 0.084 DBMET01401 | DBMET01401 | |
| 0.153 | 0.074 | 0.172 | Interferon gamma antagonist | 0.172 0.055 DBMET01401 | DBMET01401 | |
| 0.102 | 0.025 | 0.119 | Phenylalanine 4-hydroxylase inhibitor | 0.119 0.019 DBMET01401 | DBMET01401 | |
| 0.143 | 0.066 | 0.143 | Neurotrophic factor | 0.134 0.076 DBMET01401 | ||
| 0.088 | 0.011 | 0.088 | Calcitonin receptor agonist | 0.087 0.011 DBMET01401 | ||
| 0.108 | 0.033 | 0.108 | Transcription factor NF kappa B stimulant | 0.103 0.036 DBMET01401 | ||
| 0.13 | 0.056 | 0.14 | Protein-tyrosine phosphatase 1B inhibitor | 0.14 0.05 DBMET01401 | DBMET01401 | |
| 0.096 | 0.022 | 0.097 | Elastase 1 inhibitor | 0.097 0.022 DBMET01401 | DBMET01401 | |
| 0.125 | 0.051 | 0.191 | Falcipain 3 inhibitor | 0.191 0.02 DBMET01401 | DBMET01401 | |
| 0.104 | 0.03 | 0.164 | Metalloproteinase-9 inhibitor | 0.164 0.013 DBMET01401 | DBMET01401 | |
| 0.129 | 0.056 | 0.129 | Monophenol monooxygenase inhibitor | 0.097 0.079 DBMET01401 | ||
| 0.09 | 0.017 | 0.09 | Interferon inducer | 0.068 0.038 DBMET01401 | ||
| 0.122 | 0.05 | 0.142 | Nav1.4 sodium channel blocker | 0.142 0.037 DBMET01401 | DBMET01401 | |
| 0.08 | 0.009 | 0.08 | Leukotriene A4 hydrolase inhibitor | 0.079 0.009 DBMET01401 | ||
| 0.084 | 0.012 | 0.099 | Angiotensin-converting enzyme inhibitor | 0.099 0.009 DBMET01401 | DBMET01401 | |
| 0.093 | 0.022 | 0.093 | GABA B receptor agonist | 0.083 0.035 DBMET01401 | ||
| 0.117 | 0.047 | 0.122 | Toll-Like receptor 4 antagonist | 0.122 0.042 DBMET01401 | DBMET01401 | |
| 0.077 | 0.007 | 0.163 | Kainate receptor 2 antagonist | 0.163 0.003 DBMET01401 | DBMET01401 | |
| 0.093 | 0.026 | 0.104 | Glucagon-like peptide 1 agonist | 0.104 0.019 DBMET01401 | DBMET01401 | |
| 0.091 | 0.025 | 0.122 | Vanilloid 4 agonist | 0.122 0.006 DBMET01401 | DBMET01401 | |
| 0.088 | 0.022 | 0.108 | Cathepsin D inhibitor | 0.108 0.016 DBMET01401 | DBMET01401 | |
| 0.077 | 0.013 | 0.177 | Macrophage elastase inhibitor | 0.177 0.005 DBMET01401 | DBMET01401 | |
| 0.085 | 0.022 | 0.086 | Cathepsin B inhibitor | 0.086 0.021 DBMET01401 | DBMET01401 | |
| 0.112 | 0.05 | 0.116 | Carbonic anhydrase III inhibitor | 0.116 0.047 DBMET01401 | DBMET01401 | |
| 0.071 | 0.009 | 0.085 | Glutamate (mGluR group III) antagonist | 0.085 0.007 DBMET01401 | DBMET01401 | |
| 0.071 | 0.01 | 0.079 | Immunoglobulin Fc receptor antagonist | 0.079 0.006 DBMET01401 | DBMET01401 | |
| 0.114 | 0.054 | 0.114 | Mediator release inhibitor | |||
| 0.081 | 0.022 | 0.093 | Prostaglandin F2 alpha antagonist | 0.093 0.014 DBMET01401 | DBMET01401 | |
| 0.074 | 0.015 | 0.082 | Thromboxane synthase inhibitor | 0.082 0.011 DBMET01401 | DBMET01401 | |
| 0.069 | 0.01 | 0.077 | Glutamate (mGluR4) antagonist | 0.077 0.009 DBMET01401 | DBMET01401 | |
| 0.091 | 0.033 | 0.091 | Peroxisome proliferator-activated receptor gamma agonist | 0.087 0.036 DBMET01401 | ||
| 0.089 | 0.032 | 0.119 | Selectin antagonist | 0.119 0.022 DBMET01401 | DBMET01401 | |
| 0.079 | 0.023 | 0.095 | Cathepsin E inhibitor | 0.095 0.015 DBMET01401 | DBMET01401 | |
| 0.088 | 0.032 | 0.123 | Sphingosine 1-phosphate receptor 4 agonist | 0.123 0.016 DBMET01401 | DBMET01401 | |
| 0.122 | 0.066 | 0.127 | Adenylate cyclase inhibitor | 0.127 0.062 DBMET01401 | DBMET01401 | |
| 0.091 | 0.036 | 0.091 | Histidine decarboxylase inhibitor | 0.088 0.037 DBMET01401 | ||
| 0.064 | 0.009 | 0.102 | Membrane dipeptidase inhibitor | 0.102 0.004 DBMET01401 | DBMET01401 | |
| 0.158 | 0.105 | 0.158 | P-glycoprotein inhibitor | |||
| 0.095 | 0.042 | 0.099 | Hematopoietic | 0.099 0.036 DBMET01401 | DBMET01401 | |
| 0.072 | 0.02 | 0.165 | Glycine transporter 2 inhibitor | 0.165 0.007 DBMET01401 | DBMET01401 | |
| 0.063 | 0.011 | 0.065 | Neurokinin 2 agonist | 0.065 0.01 DBMET01401 | DBMET01401 | |
| 0.079 | 0.028 | 0.079 | Beta adrenoreceptor antagonist | |||
| 0.062 | 0.011 | 0.075 | Cholecystokinin B agonist | 0.075 0.008 DBMET01401 | DBMET01401 | |
| 0.088 | 0.038 | 0.143 | Glutamate decarboxylase inhibitor | 0.143 0.014 DBMET01401 | DBMET01401 | |
| 0.081 | 0.031 | 0.09 | Neuropeptide agonist | 0.09 0.029 DBMET01401 | DBMET01401 | |
| 0.055 | 0.005 | 0.067 | Integrin alpha1beta1 antagonist | 0.067 0.004 DBMET01401 | DBMET01401 | |
| 0.061 | 0.011 | 0.07 | HIV-1 protease inhibitor | 0.07 0.007 DBMET01401 | DBMET01401 | |
| 0.051 | 0.004 | 0.174 | Aminopeptidase A inhibitor | 0.174 0.001 DBMET01401 | DBMET01401 | |
| 0.101 | 0.054 | 0.124 | Falcipain inhibitor | 0.124 0.042 DBMET01401 | DBMET01401 | |
| 0.063 | 0.017 | 0.063 | Leukocyte elastase inhibitor | 0.061 0.018 DBMET01401 | ||
| 0.117 | 0.071 | 0.119 | DNA polymerase I inhibitor | 0.119 0.069 DBMET01401 | DBMET01401 | |
| 0.049 | 0.004 | 0.049 | Lysophosphatidic acid receptor 1 agonist | 0.049 0.004 DBMET01401 | ||
| 0.062 | 0.018 | 0.092 | Cholecystokinin antagonist | 0.092 0.009 DBMET01401 | DBMET01401 | |
| 0.055 | 0.01 | 0.108 | Integrin alpha4 antagonist | 0.108 0.005 DBMET01401 | DBMET01401 | |
| 0.06 | 0.016 | 0.092 | Cholecystokinin A antagonist | 0.092 0.01 DBMET01401 | DBMET01401 | |
| 0.052 | 0.009 | 0.079 | Peptide deformylase inhibitor | 0.079 0.004 DBMET01401 | DBMET01401 | |
| 0.082 | 0.04 | 0.082 | Epoxide hydrolase inhibitor | 0.068 0.056 DBMET01401 | ||
| 0.096 | 0.054 | 0.119 | Falcipain 2 inhibitor | 0.119 0.043 DBMET01401 | DBMET01401 | |
| 0.065 | 0.024 | 0.065 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.068 | 0.028 | 0.073 | Gonadotropin-releasing hormone receptor agonist | 0.073 0.023 DBMET01401 | DBMET01401 | |
| 0.143 | 0.103 | 0.143 | Antipruritic | |||
| 0.064 | 0.024 | 0.067 | Leukotriene B4 antagonist | 0.067 0.022 DBMET01401 | DBMET01401 | |
| 0.096 | 0.056 | 0.096 | ABCA1 expression enhancer | 0.091 0.064 DBMET01401 | ||
| 0.045 | 0.005 | 0.119 | Integrin alpha4beta1 antagonist | 0.119 0.004 DBMET01401 | DBMET01401 | |
| 0.052 | 0.012 | 0.097 | Kainate receptor agonist | 0.097 0.003 DBMET01401 | DBMET01401 | |
| 0.115 | 0.076 | 0.115 | Aldehyde dehydrogenase inhibitor | |||
| 0.059 | 0.022 | 0.081 | HCV NS3/NS4A protease inhibitor | 0.081 0.01 DBMET01401 | DBMET01401 | |
| 0.086 | 0.049 | 0.09 | Caspase 7 inhibitor | 0.09 0.041 DBMET01401 | DBMET01401 | |
| 0.076 | 0.04 | 0.083 | Peroxisome proliferator-activated receptor gamma antagonist | 0.083 0.03 DBMET01401 | DBMET01401 | |
| 0.052 | 0.016 | 0.066 | Plasmepsin II inhibitor | 0.066 0.009 DBMET01401 | DBMET01401 | |
| 0.059 | 0.024 | 0.062 | Carbonic anhydrase II stimulant | 0.062 0.021 DBMET01401 | DBMET01401 | |
| 0.04 | 0.004 | 0.045 | Lysophosphatidic acid 1 receptor antagonist | 0.045 0.004 DBMET01401 | DBMET01401 | |
| 0.075 | 0.04 | 0.082 | Sirtuin 1 inhibitor | 0.082 0.034 DBMET01401 | DBMET01401 | |
| 0.038 | 0.004 | 0.043 | Caspase 8 inhibitor | 0.043 0.003 DBMET01401 | DBMET01401 | |
| 0.066 | 0.032 | 0.066 | Cathepsin L inhibitor | 0.064 0.034 DBMET01401 | ||
| 0.109 | 0.076 | 0.119 | Cholesterol synthesis inhibitor | 0.119 0.066 DBMET01401 | DBMET01401 | |
| 0.088 | 0.055 | 0.088 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.136 | 0.103 | 0.154 | Melanin inhibitor | 0.154 0.077 DBMET01401 | DBMET01401 | |
| 0.046 | 0.013 | 0.062 | Caspase 2 inhibitor | 0.062 0.009 DBMET01401 | DBMET01401 | |
| 0.163 | 0.131 | 0.163 | Free radical scavenger | |||
| 0.062 | 0.031 | 0.062 | Lipocortins synthesis agonist | |||
| 0.054 | 0.023 | 0.084 | Thymidylate synthase inhibitor | 0.084 0.006 DBMET01401 | DBMET01401 | |
| 0.058 | 0.027 | 0.063 | Prolyl endopeptidase inhibitor | 0.063 0.021 DBMET01401 | DBMET01401 | |
| 0.046 | 0.015 | 0.049 | Prostacyclin antagonist | 0.049 0.013 DBMET01401 | DBMET01401 | |
| 0.09 | 0.059 | 0.093 | Aminoacyl-tRNA synthetase inhibitor | 0.093 0.053 DBMET01401 | DBMET01401 | |
| 0.054 | 0.024 | 0.062 | Collagenase inhibitor | 0.062 0.014 DBMET01401 | DBMET01401 | |
| 0.045 | 0.014 | 0.048 | VCAM-1 antagonist | 0.048 0.01 DBMET01401 | DBMET01401 | |
| 0.045 | 0.014 | 0.048 | VCAM antagonist | 0.048 0.01 DBMET01401 | DBMET01401 | |
| 0.07 | 0.04 | 0.082 | Leukotriene antagonist | 0.082 0.03 DBMET01401 | DBMET01401 | |
| 0.058 | 0.028 | 0.084 | Aconitate hydratase inhibitor | 0.084 0.012 DBMET01401 | DBMET01401 | |
| 0.036 | 0.006 | 0.085 | Glutamate (mGluR1) agonist | 0.085 0.004 DBMET01401 | DBMET01401 | |
| 0.04 | 0.01 | 0.042 | Calpain 1 inhibitor | 0.042 0.008 DBMET01401 | DBMET01401 | |
| 0.055 | 0.025 | 0.085 | Neurotensin receptor antagonist | 0.085 0.017 DBMET01401 | DBMET01401 | |
| 0.051 | 0.021 | 0.087 | AICAR transformylase inhibitor | 0.087 0.006 DBMET01401 | DBMET01401 | |
| 0.057 | 0.027 | 0.057 | Beta 2 adrenoreceptor antagonist | |||
| 0.042 | 0.013 | 0.042 | Trypsin II inhibitor | |||
| 0.053 | 0.025 | 0.058 | Bombesin antagonist | 0.058 0.02 DBMET01401 | DBMET01401 | |
| 0.124 | 0.096 | 0.124 | Farnesoid X receptor antagonist | |||
| 0.041 | 0.014 | 0.044 | HMG CoA reductase inhibitor | 0.044 0.01 DBMET01401 | DBMET01401 | |
| 0.054 | 0.027 | 0.062 | CD45 antagonist | 0.062 0.02 DBMET01401 | DBMET01401 | |
| 0.036 | 0.011 | 0.04 | Caspase 6 inhibitor | 0.04 0.008 DBMET01401 | DBMET01401 | |
| 0.063 | 0.038 | 0.08 | Collagenase 3 inhibitor | 0.08 0.025 DBMET01401 | DBMET01401 | |
| 0.038 | 0.013 | 0.038 | Calcium-independent phospholipase A2 inhibitor | 0.035 0.02 DBMET01401 | ||
| 0.045 | 0.02 | 0.19 | AMPA 4 receptor antagonist | 0.19 0.003 DBMET01401 | DBMET01401 | |
| 0.092 | 0.068 | 0.103 | Bile acid receptor antagonist | 0.103 0.043 DBMET01401 | DBMET01401 | |
| 0.062 | 0.039 | 0.075 | Bombesin 1 receptor agonist | 0.075 0.028 DBMET01401 | DBMET01401 | |
| 0.134 | 0.113 | 0.134 | Nitric oxide antagonist | 0.126 0.125 DBMET01401 | ||
| 0.036 | 0.015 | 0.043 | Plasmepsin I inhibitor | 0.043 0.01 DBMET01401 | DBMET01401 | |
| 0.075 | 0.054 | 0.093 | Analgesic, opioid | 0.093 0.036 DBMET01401 | DBMET01401 | |
| 0.054 | 0.033 | 0.068 | Thromboxane A2 antagonist | 0.068 0.022 DBMET01401 | DBMET01401 | |
| 0.057 | 0.036 | 0.077 | Bombesin 3 receptor antagonist | 0.077 0.02 DBMET01401 | DBMET01401 | |
| 0.042 | 0.022 | 0.043 | Glucagon-like peptide 1 receptor antagonist | 0.043 0.021 DBMET01401 | DBMET01401 | |
| 0.025 | 0.005 | 0.088 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.088 0.003 DBMET01401 | DBMET01401 | |
| 0.042 | 0.022 | 0.048 | Renin inhibitor | 0.048 0.019 DBMET01401 | DBMET01401 | |
| 0.036 | 0.017 | 0.059 | Cholecystokinin B antagonist | 0.059 0.009 DBMET01401 | DBMET01401 | |
| 0.036 | 0.017 | 0.042 | Carboxypeptidase B inhibitor | 0.042 0.011 DBMET01401 | DBMET01401 | |
| 0.055 | 0.036 | 0.072 | Thromboxane antagonist | 0.072 0.025 DBMET01401 | DBMET01401 | |
| 0.034 | 0.016 | 0.072 | VLA-4 antagonist | 0.072 0.009 DBMET01401 | DBMET01401 | |
| 0.047 | 0.028 | 0.063 | Complement C3a chemotactic receptor antagonist | 0.063 0.02 DBMET01401 | DBMET01401 | |
| 0.035 | 0.016 | 0.036 | Lysophosphatidic acid 2 receptor antagonist | 0.036 0.015 DBMET01401 | DBMET01401 | |
| 0.044 | 0.025 | 0.058 | Erythropoietin receptor agonist | 0.058 0.018 DBMET01401 | DBMET01401 | |
| 0.03 | 0.012 | 0.03 | Thyroid hormone agonist | 0.024 0.023 DBMET01401 | ||
| 0.035 | 0.017 | 0.103 | AMPA 3 receptor antagonist | 0.103 0.004 DBMET01401 | DBMET01401 | |
| 0.027 | 0.01 | 0.042 | Integrin alpha4beta7 antagonist | 0.042 0.006 DBMET01401 | DBMET01401 | |
| 0.053 | 0.036 | 0.087 | Matrix metalloproteinase 1 inhibitor | 0.087 0.018 DBMET01401 | DBMET01401 | |
| 0.074 | 0.058 | 0.074 | Keratolytic | 0.074 0.058 DBMET01401 | ||
| 0.036 | 0.02 | 0.042 | Angiotensin II receptor antagonist | 0.042 0.012 DBMET01401 | DBMET01401 | |
| 0.034 | 0.018 | 0.036 | Methionyl aminopeptidase 1 inhibitor | 0.036 0.016 DBMET01401 | DBMET01401 | |
| 0.025 | 0.01 | 0.025 | Isoleucine-tRNA ligase inhibitor | 0.022 0.018 DBMET01401 | ||
| 0.043 | 0.028 | 0.051 | Angiotensin AT1 receptor antagonist | 0.051 0.016 DBMET01401 | DBMET01401 | |
| 0.042 | 0.028 | 0.048 | Cathepsin F inhibitor | 0.048 0.015 DBMET01401 | DBMET01401 | |
| 0.051 | 0.038 | 0.076 | Ornithine carbamoyltransferase inhibitor | 0.076 0.023 DBMET01401 | DBMET01401 | |
| 0.036 | 0.024 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.038 0.021 DBMET01401 | DBMET01401 | |
| 0.033 | 0.021 | 0.049 | Glutamate (mGluR3) agonist | 0.049 0.005 DBMET01401 | DBMET01401 | |
| 0.06 | 0.049 | 0.06 | Trypsin inhibitor | |||
| 0.067 | 0.056 | 0.067 | Calcium channel L-type blocker | |||
| 0.04 | 0.029 | 0.046 | Integrin alpha5beta1 antagonist | 0.046 0.022 DBMET01401 | DBMET01401 | |
| 0.115 | 0.105 | 0.259 | Peroxidase inhibitor | 0.259 0.046 DBMET01401 | DBMET01401 | |
| 0.029 | 0.019 | 0.043 | Leukotriene B4 receptor 1 antagonist | 0.043 0.01 DBMET01401 | DBMET01401 | |
| 0.035 | 0.025 | 0.048 | Glutamate (mGluR8) antagonist | 0.048 0.009 DBMET01401 | DBMET01401 | |
| 0.022 | 0.012 | 0.039 | Integrin beta7 antagonist | 0.039 0.008 DBMET01401 | DBMET01401 | |
| 0.089 | 0.08 | 0.089 | Gastric antisecretory | |||
| 0.022 | 0.013 | 0.033 | Neurokinin 1 agonist | 0.033 0.009 DBMET01401 | DBMET01401 | |
| 0.032 | 0.022 | 0.039 | Squalene synthetase inhibitor | 0.039 0.019 DBMET01401 | DBMET01401 | |
| 0.036 | 0.027 | 0.044 | 5-Alpha-reductase inhibitor | 0.044 0.021 DBMET01401 | DBMET01401 | |
| 0.04 | 0.031 | 0.06 | Oxytocin agonist | 0.06 0.017 DBMET01401 | DBMET01401 | |
| 0.063 | 0.054 | 0.113 | Phosphofructokinase-1 inhibitor | 0.113 0.027 DBMET01401 | DBMET01401 | |
| 0.079 | 0.07 | 0.107 | Opioid antagonist | 0.107 0.043 DBMET01401 | DBMET01401 | |
| 0.136 | 0.128 | 0.146 | Lipocortins synthesis antagonist | 0.146 0.111 DBMET01401 | DBMET01401 | |
| 0.035 | 0.027 | 0.053 | Arginase inhibitor | 0.053 0.014 DBMET01401 | DBMET01401 | |
| 0.035 | 0.027 | 0.09 | Glutamate (mGluR3) antagonist | 0.09 0.005 DBMET01401 | DBMET01401 | |
| 0.016 | 0.008 | 0.019 | Integrin alphaVbeta6 antagonist | 0.019 0.006 DBMET01401 | DBMET01401 | |
| 0.052 | 0.044 | 0.141 | Argininosuccinate synthase inhibitor | 0.141 0.012 DBMET01401 | DBMET01401 | |
| 0.038 | 0.03 | 0.042 | GABA uptake inhibitor | 0.042 0.024 DBMET01401 | DBMET01401 | |
| 0.021 | 0.015 | 0.095 | Kainate receptor 1 antagonist | 0.095 0.004 DBMET01401 | DBMET01401 | |
| 0.054 | 0.048 | 0.057 | Leukotriene C antagonist | 0.057 0.037 DBMET01401 | DBMET01401 | |
| 0.143 | 0.138 | 0.143 | Anticonvulsant | |||
| 0.027 | 0.022 | 0.069 | AMPA 1 receptor antagonist | 0.069 0.008 DBMET01401 | DBMET01401 | |
| 0.049 | 0.044 | 0.049 | Elastase inhibitor | 0.048 0.045 DBMET01401 | ||
| 0.013 | 0.008 | 0.016 | Calcium-dependent phospholipase A2 inhibitor | 0.016 0.005 DBMET01401 | DBMET01401 | |
| 0.026 | 0.022 | 0.032 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.032 0.012 DBMET01401 | DBMET01401 | |
| 0.082 | 0.078 | 0.084 | Thioredoxin inhibitor | 0.084 0.072 DBMET01401 | DBMET01401 | |
| 0.017 | 0.013 | 0.028 | Angiotensin-converting enzyme 2 inhibitor | 0.028 0.005 DBMET01401 | DBMET01401 | |
| 0.032 | 0.029 | 0.037 | HCV polyprotein inhibitor | 0.037 0.017 DBMET01401 | DBMET01401 | |
| 0.021 | 0.018 | 0.021 | Prostaglandin F2 alpha agonist | 0.021 0.018 DBMET01401 | ||
| 0.033 | 0.03 | 0.039 | Growth factor receptor-bound protein 2 antagonist | 0.039 0.015 DBMET01401 | DBMET01401 | |
| 0.034 | 0.031 | 0.049 | Carbonic anhydrase I stimulant | 0.049 0.017 DBMET01401 | DBMET01401 | |
| 0.039 | 0.037 | 0.057 | Protease activated receptor 1 antagonist | 0.057 0.029 DBMET01401 | DBMET01401 | |
| 0.033 | 0.032 | 0.035 | Tryptophan 5 hydroxylase inhibitor | 0.035 0.027 DBMET01401 | DBMET01401 | |
| 0.012 | 0.011 | 0.012 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.034 | 0.033 | 0.034 | Integrin alpha2 antagonist | |||
| 0.17 | 0.169 | 0.177 | DNA synthesis inhibitor | 0.177 0.157 DBMET01401 | DBMET01401 | |
| 0.015 | 0.015 | 0.024 | Ileal bile acid transport inhibitor | 0.024 0.007 DBMET01401 | DBMET01401 | |
| 0.052 | 0.053 | 0.076 | Opioid delta receptor antagonist | 0.076 0.038 DBMET01401 | DBMET01401 | |
| 0.03 | 0.032 | 0.033 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.033 0.026 DBMET01401 | DBMET01401 | |
| 0.019 | 0.022 | 0.025 | Aminopeptidase P inhibitor | 0.025 0.014 DBMET01401 | DBMET01401 | |
| 0.018 | 0.021 | 0.027 | Integrin alphaVbeta3 antagonist | 0.027 0.01 DBMET01401 | DBMET01401 | |
| 0.049 | 0.052 | 0.068 | Sphingosine 1-phosphate receptor 5 agonist | 0.068 0.017 DBMET01401 | DBMET01401 | |
| 0.014 | 0.017 | 0.019 | Cholecystokinin agonist | 0.019 0.013 DBMET01401 | DBMET01401 | |
| 0.056 | 0.059 | 0.081 | Opioid mu receptor antagonist | 0.081 0.039 DBMET01401 | DBMET01401 | |
| 0.013 | 0.017 | 0.015 | Cholecystokinin A agonist | 0.015 0.012 DBMET01401 | DBMET01401 | |
| 0.006 | 0.01 | 0.007 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.007 0.006 DBMET01401 | DBMET01401 | |
| 0.017 | 0.021 | 0.023 | Human T-cell leukemia virus type I protease inhibitor | 0.023 0.013 DBMET01401 | DBMET01401 | |
| 0.078 | 0.085 | 0.136 | Prolactin inhibitor | 0.136 0.029 DBMET01401 | DBMET01401 | |
| 0.047 | 0.055 | 0.056 | Heparanase inhibitor | 0.056 0.031 DBMET01401 | DBMET01401 | |
| 0.016 | 0.024 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.01 DBMET01401 | DBMET01401 | |
| 0.015 | 0.024 | 0.018 | Integrin alphaVbeta1 antagonist | 0.018 0.015 DBMET01401 | DBMET01401 | |
| 0.012 | 0.024 | 0.023 | Kainate receptor 3 antagonist | 0.023 0.007 DBMET01401 | DBMET01401 | |
| 0.02 | 0.032 | 0.04 | Lysine carboxypeptidase inhibitor | 0.04 0.01 DBMET01401 | DBMET01401 | |
| 0.089 | 0.102 | 0.125 | DOPA decarboxylase inhibitor | 0.125 0.039 DBMET01401 | DBMET01401 | |
| 0.063 | 0.077 | 0.08 | Somatostatin 1 agonist | 0.08 0.052 DBMET01401 | DBMET01401 | |
| 0.01 | 0.024 | 0.014 | Carbonic anhydrase IV stimulant | 0.014 0.012 DBMET01401 | DBMET01401 | |
| 0.014 | 0.028 | 0.022 | Vitronectin receptor antagonist | 0.022 0.014 DBMET01401 | DBMET01401 | |
| 0.022 | 0.037 | 0.033 | Thrombin receptor antagonist | 0.033 0.015 DBMET01401 | DBMET01401 | |
| 0.095 | 0.11 | 0.118 | Interleukin 8 antagonist | 0.118 0.064 DBMET01401 | DBMET01401 | |
| 0.08 | 0.095 | 0.175 | GABA C receptor agonist | 0.175 0.026 DBMET01401 | DBMET01401 | |
| 0.018 | 0.036 | 0.038 | AMPA 2 receptor antagonist | 0.038 0.015 DBMET01401 | DBMET01401 | |
| 0.024 | 0.042 | 0.055 | Fumarate hydratase inhibitor | 0.055 0.012 DBMET01401 | DBMET01401 | |
| 0.015 | 0.034 | 0.034 | Kainate receptor 4 antagonist | 0.034 0.012 DBMET01401 | DBMET01401 | |
| 0.072 | 0.093 | 0.092 | Triose-phosphate isomerase inhibitor | 0.092 0.056 DBMET01401 | DBMET01401 | |
| 0.044 | 0.066 | 0.062 | Carbamoyl phosphate synthetase inhibitor | 0.062 0.041 DBMET01401 | DBMET01401 | |
| 0.083 | 0.107 | 0.105 | Adenylate kinase inhibitor | 0.105 0.06 DBMET01401 | DBMET01401 | |
| 0.045 | 0.07 | 0.082 | NMDA 2C receptor antagonist | 0.082 0.024 DBMET01401 | DBMET01401 | |
| 0.031 | 0.055 | 0.037 | Aggrecanase 1 inhibitor | 0.037 0.032 DBMET01401 | DBMET01401 | |
| 0.037 | 0.063 | 0.048 | Glucose-6-phosphate isomerase inhibitor | 0.048 0.033 DBMET01401 | DBMET01401 | |
| 0.024 | 0.053 | 0.032 | Histone deacetylase 7 inhibitor | 0.032 0.031 DBMET01401 | DBMET01401 | |
| 0.134 | 0.164 | 0.161 | Neurotrophic factor enhancer | 0.161 0.123 DBMET01401 | DBMET01401 | |
| 0.01 | 0.041 | 0.023 | Kainate receptor 5 antagonist | 0.023 0.013 DBMET01401 | DBMET01401 | |
| 0.029 | 0.06 | 0.045 | Glutamate (mGluR8) agonist | 0.045 0.015 DBMET01401 | DBMET01401 | |
| 0.015 | 0.046 | 0.027 | Prostaglandin EP3 antagonist | 0.027 0.025 DBMET01401 | DBMET01401 | |
| 0.106 | 0.138 | 0.116 | Sphingosine 1-phosphate receptor 2 antagonist | 0.116 0.108 DBMET01401 | DBMET01401 | |
| 0.013 | 0.045 | 0.02 | Geranylgeranyltransferase inhibitor | 0.02 0.018 DBMET01401 | DBMET01401 | |
| 0.021 | 0.056 | 0.035 | Cathepsin L2 inhibitor | 0.035 0.033 DBMET01401 | DBMET01401 | |
| 0.017 | 0.054 | 0.031 | LFA antagonist | 0.031 0.015 DBMET01401 | DBMET01401 | |
| 0.022 | 0.06 | 0.04 | Dipeptidyl peptidase II inhibitor | 0.04 0.014 DBMET01401 | DBMET01401 | |
| 0.054 | 0.096 | 0.067 | CDC25A inhibitor | 0.067 0.062 DBMET01401 | DBMET01401 | |
| 0.073 | 0.115 | 0.091 | Anabolic | 0.091 0.076 DBMET01401 | DBMET01401 | |
| 0.016 | 0.06 | 0.022 | ICAM 1 antagonist | 0.022 0.02 DBMET01401 | DBMET01401 | |
| 0.083 | 0.128 | 0.096 | TRPA1 agonist | 0.096 0.095 DBMET01401 | DBMET01401 | |
| 0.115 | 0.161 | 0.147 | Interleukin 6 antagonist | 0.147 0.094 DBMET01401 | DBMET01401 | |
| 0.042 | 0.088 | 0.052 | DNA helicase inhibitor | 0.052 0.043 DBMET01401 | DBMET01401 | |
| 0.032 | 0.081 | 0.059 | Prostaglandin EP2 antagonist | 0.059 0.042 DBMET01401 | DBMET01401 | |
| 0.008 | 0.059 | 0.024 | Prostaglandin H2 antagonist | 0.024 0.019 DBMET01401 | DBMET01401 | |
| 0.011 | 0.071 | 0.032 | Glucagon receptor antagonist | 0.032 0.018 DBMET01401 | DBMET01401 | |
| 0.018 | 0.078 | 0.034 | NMDA receptor subunit 3A antagonist | 0.034 0.031 DBMET01401 | DBMET01401 | |
| 0.014 | 0.077 | 0.025 | NMDA 2D receptor antagonist | 0.025 0.022 DBMET01401 | DBMET01401 | |
| 0.06 | 0.125 | 0.08 | Alcohol dehydrogenase inhibitor | 0.08 0.079 DBMET01401 | DBMET01401 | |
| 0.046 | 0.125 | 0.075 | Secretase beta inhibitor | 0.075 0.043 DBMET01401 | DBMET01401 | |
| 0.016 | 0.095 | 0.032 | ATP citrate lysase inhibitor | 0.032 0.022 DBMET01401 | DBMET01401 | |
| 0.042 | 0.128 | 0.071 | Phospholipase D inhibitor | 0.071 0.051 DBMET01401 | DBMET01401 | |
| 0.033 | 0.123 | 0.055 | Botulinum neurotoxin type A inhibitor | 0.055 0.047 DBMET01401 | DBMET01401 | |
| 0.021 | 0.115 | 0.049 | NMDA receptor subunit 3B antagonist | 0.049 0.026 DBMET01401 | DBMET01401 | |
| 0.205 | 0.312 | 0.264 | Caspase 9 stimulant | 0.264 0.235 DBMET01401 | DBMET01401 | |
| 0.053 | 0.168 | 0.138 | Ferrochelatase inhibitor | 0.138 0.043 DBMET01401 | DBMET01401 | |
| 0.047 | 0.175 | 0.085 | HIV-1 integrase (Overall Integration) inhibitor | 0.085 0.071 DBMET01401 | DBMET01401 | |
| 0.029 | 0.164 | 0.07 | Porphobilinogen synthase inhibitor | 0.07 0.056 DBMET01401 | DBMET01401 | |
| 0.084 | 0.256 | 0.156 | Antiamyloidogenic | 0.156 0.139 DBMET01401 | DBMET01401 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |